SHC Sotera Health Co revenue, earnings and financials

For the quarter ended June 30, 2026, Sotera Health Co reported revenue of $321M (up 9.2% from a year earlier), net income of $53.6M and diluted EPS of $0.19; over the last four quarters revenue was $1.22B and net income $163M; for the fiscal year ended December 2025 revenue was $1.16B, up 5.7% on the year before.

SHC annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $1.16B, gross profit $646M, operating income n/a, net income $77.9M (margin 6.7%), EPS $0.27
• Fiscal year ended Dec 2024: revenue $1.10B, gross profit $602M, operating income $298M, net income $44.4M (margin 4.0%), EPS $0.16
• Fiscal year ended Dec 2023: revenue $1.05B, gross profit $577M, operating income $277M, net income $51.4M (margin 4.9%), EPS $0.18
• Fiscal year ended Dec 2022: revenue $1.00B, gross profit $557M, operating income $248M, net income −$234M (margin -23.3%), EPS −$0.83
• Fiscal year ended Dec 2021: revenue $931M, gross profit $519M, operating income $257M, net income $116M (margin 12.5%), EPS $0.41

SHC quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $321M (up 9.2% year over year), net income $53.6M, EPS $0.19
• Quarter ended Mar 31, 2026: revenue $280M (up 10.0% year over year), net income $26.6M, EPS $0.09
• Quarter ended Dec 31, 2025 (from the annual report): revenue $303M (up 4.6% year over year), net income $34.8M, EPS $0.12
• Quarter ended Sep 30, 2025: revenue $311M (up 9.1% year over year), net income $48.4M, EPS $0.17
• Quarter ended Jun 30, 2025: revenue $294M (up 6.4% year over year), net income $7.96M, EPS $0.03
• Quarter ended Mar 31, 2025: revenue $255M (up 2.6% year over year), net income −$13.3M, EPS −$0.05
• Quarter ended Dec 31, 2024 (from the annual report): revenue $290M (down 6.5% year over year), net income $12.3M, EPS $0.05
• Quarter ended Sep 30, 2024: revenue $285M (up 8.5% year over year), net income $17.0M, EPS $0.06
• Quarter ended Jun 30, 2024: revenue $277M (up 8.3% year over year), net income $8.75M, EPS $0.03
• Quarter ended Mar 31, 2024: revenue $248M (up 12.5% year over year), net income $6.32M, EPS $0.02
• Quarter ended Dec 31, 2023 (from the annual report): revenue $310M (up 23.3% year over year), net income $38.7M, EPS $0.14
• Quarter ended Sep 30, 2023: revenue $263M (up 5.8% year over year), net income −$13.7M, EPS −$0.05
• Quarter ended Jun 30, 2023: revenue $255M (down 4.3% year over year), net income $23.5M, EPS $0.08
• Quarter ended Mar 31, 2023: revenue $221M (down 6.8% year over year), net income $2.84M, EPS $0.01
• Quarter ended Dec 31, 2022 (from the annual report): revenue $252M (up 4.3% year over year), net income −$408M, EPS −$1.14
• Quarter ended Sep 30, 2022: revenue $249M (up 10.0% year over year), net income $25.1M, EPS $0.09
• Quarter ended Jun 30, 2022: revenue $267M (up 5.8% year over year), net income $30.4M, EPS $0.11
• Quarter ended Mar 31, 2022: revenue $237M (up 11.6% year over year), net income $30.6M, EPS $0.11
• Quarter ended Dec 31, 2021 (from the annual report): revenue $241M, net income $35.3M, EPS $0.12
• Quarter ended Sep 30, 2021: revenue $226M, net income $27.4M, EPS $0.10

SHC cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $287M, share buybacks n/a
• Fiscal year ended Dec 2024: operating cash flow $224M, share buybacks n/a
• Fiscal year ended Dec 2023: operating cash flow −$148M, share buybacks n/a
• Fiscal year ended Dec 2022: operating cash flow $278M, share buybacks $0
• Fiscal year ended Dec 2021: operating cash flow $282M, share buybacks $0

SHC balance sheet

• Jun 30, 2026: cash $357M, total assets $3.31B, total liabilities $2.64B, shareholders' equity $666M, long-term debt $2.13B
• Mar 31, 2026: cash $314M, total assets $3.24B, total liabilities $2.61B, shareholders' equity $623M, long-term debt $2.12B
• Dec 31, 2025: cash $345M, total assets $3.26B, total liabilities $2.66B, shareholders' equity $606M, long-term debt $2.13B
• Sep 30, 2025: cash $299M, total assets $3.19B, total liabilities $2.64B, shareholders' equity $550M, long-term debt $2.13B
• Jun 30, 2025: cash $332M, total assets $3.22B, total liabilities $2.71B, shareholders' equity $511M, long-term debt $2.20B
• Mar 31, 2025: cash $304M, total assets $3.10B, total liabilities $2.68B, shareholders' equity $414M, long-term debt $2.21B
• Dec 31, 2024: cash $277M, total assets $3.07B, total liabilities $2.67B, shareholders' equity $405M, long-term debt $2.21B
• Sep 30, 2024: cash $307M, total assets $3.15B, total liabilities $2.68B, shareholders' equity $470M, long-term debt $2.21B

What is SHC's revenue?

Sotera Health Co reported $1.22B of revenue over its last four quarters, through June 30, 2026.

Is SHC profitable?

Yes. Sotera Health Co earned $163M over the last four quarters.

What is SHC's EPS?

Diluted earnings per share over the last four quarters were $0.57; $0.19 in the latest quarter.

SHC ownership and insider trades · All stocks